Medtech Insight
>>Geography
>>Asia

Experts: Chinese Tariff Cuts Good For Medtech, But Deliver Small Impact

13 Feb 2020

Two top trade experts tell Medtech Insight that China’s recent decision to reduce tariffs is in response to the US government’s announcement that it, too, would reduce tariffs in an apparent bid to deescalate the seemingly never-ending trade war. Dropping tariffs will also help China meet its obligations under a so-called Phase 1 trade deal agreed to by the two countries.

USA and China trade war. US of America and chinese flags crashed containers on sky at sunset background. 3d illustration

The Chinese government’s plan to reduce tariffs it imposed on a slew of US exports – while good news for domestic manufacturers – will have a very minimal impact on the overall medtech industry, two trade experts with industry advocacy group AdvaMed say.

Ralph Ives, AdvaMed’s executive VP for global strategy, and Kyle Churchman, the group’s director for global strategy, said the Chinese...